<DOC>
	<DOCNO>NCT01005875</DOCNO>
	<brief_summary>This study determine safety efficacy stereotactic body radiotherapy ( SBRT ) treatment drug patient hepatocellular carcinoma .</brief_summary>
	<brief_title>Stereotactic Radiation Therapy Sorafenib Treatment Hepatocellular Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Sorafenib</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<criteria>ChildPugh class A B7 cirrhosis . No prior radiation therapy upper right abdominal quadrant . Size tumor less 6 cm . Three less know lesion . More 800 cc uninvolved liver . Age &gt; 19 year old ECOG Performance Status 0 1 Adequate bone marrow , liver renal function assess follow : Hemoglobin &gt; 8.5 g/dl Platelet count &gt; 50,000/mm3 Total bilirubin &lt; 1.5 time ULN ALT AST &lt; 2.5 time ULN ( &lt; 5 x ULN patient liver involvement ) Creatinine &lt; 1.5 time ULN Women childbearing potential must negative serum pregnancy test perform within 7 day prior start treatment Women childbearing potential men must agree use adequate contraception ( barrier method birth control ) prior study entry duration study participation . Men use adequate birth control least three month last administration sorafenib . Ability understand willingness sign write informed consent . A sign informed consent must obtain prior study specific procedure . INR &lt; 1.5 PT/PTT within normal limit . Patients receive anticoagulation treatment agent warfarin heparin may allow participate . For patient warfarin , INR measure prior initiation sorafenib monitor least weekly , define local standard care , INR stable . ChildPugh class B8 C cirrhosis . ECOG great equal 2 . Uncontrolled ascites despite medical management . Less 800 cc uninvolved liver . Prior radiotherapy upper abdominal quadrant . Prior antiangiogenic tyrosine kinase inhibitor therapy Cardiac disease : Congestive heart failure &gt; class II NYHA . Patients must unstable angina ( anginal symptom rest ) new onset angina ( begin within last 3 month ) myocardial infarction within past 6 month . Known brain metastasis . Patients neurological symptom must undergo CT scan/MRI brain exclude brain metastasis . Cardiac ventricular arrhythmia require antiarrhythmic therapy . Uncontrolled hypertension define systolic blood pressure &gt; 150 mmHg diastolic pressure &gt; 90 mmHg , despite optimal medical management . Known human immunodeficiency virus ( HIV ) infection chronic Hepatitis B C. Active clinically serious infection &gt; CTCAE Grade 2 . Thrombolic embolic event cerebrovascular accident include transient ischemic attack within past 6 month . Pulmonary hemorrhage/bleeding event &gt; CTCAE Grade 2 within 4 week first dose study drug . Any hemorrhage/bleeding event &gt; CTCAE Grade 3 within 4 week first dose study drug . Serious nonhealing wound , ulcer , bone fracture . Evidence history bleed diathesis coagulopathy Major surgery , open biopsy significant traumatic injury within 4 week first study drug . Use St. John 's Wort rifampin ( rifampicin ) . Known suspected allergy sorafenib agent give course trial . Any condition impair patient 's ability swallow whole pill . Any malabsorption problem . Pregnant lactate female .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Hepatocellular carcinoma</keyword>
	<keyword>HCC</keyword>
	<keyword>Liver Cancer</keyword>
	<keyword>adult primary hepatocellular carcinoma</keyword>
</DOC>